Business News

Global Cancer Diagnostic Devices Market | Analyzing Growth in Health Care Equipment Industry | Emerging Trends, Company Risk, and Key Executives| Technavio – Press Release

[ad_1]

NEW YORK, July 12, 2021 /PRNewswire/ — The cancer diagnostic devices market is poised to grow by USD 6.05 billion during 2021-2025, progressing at a CAGR of almost 8% during the forecast period.


Technavio has announced its latest market research report titled Cancer Diagnostic Devices Market by Product and Geography - Forecast and Analysis 2021-2025

Here is an Exclusive report talking about Market scenarios, Estimates, the impact of lockdown, and Customer Behaviour.
Get a FREE Sample Report Now!

The report on the cancer diagnostic devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.

The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by the high prevalence of cancer.

The cancer diagnostic devices market analysis includes the product segment and geographic landscape. This study identifies the need for cost-cutting in drug discovery and development as one of the prime reasons driving the cancer diagnostic devices market growth during the next few years.

This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The cancer diagnostic devices market covers the following areas:

Cancer Diagnostic Devices Market Sizing
Cancer Diagnostic Devices Market Forecast
Cancer Diagnostic Devices Market Analysis

Download the free sample report here: www.technavio.com/talk-to-us?report=IRTNTR70692

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Becton, Dickinson and Co.
  • bioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

Related Reports on Health Care Include:
Global Lung Cancer Liquid Biopsy Market
 – Global lung cancer liquid biopsy market is segmented by product (CTCs and ctDNA and Exosomes and RNA) and geography (North America, Europe, Asia, and ROW).
Download Exclusive Free Sample Report

Global Pathology Instruments Market – Global pathology instruments market is segmented by application (diagnostics, drug discovery, and other applications) and geography (North America, Europe, Asia, and ROW).
Download Exclusive Free Sample Report

Key Topics Covered:

Executive Summary

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020 – 2025

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Product

  • Market segments
  • Comparison by Product
  • Molecular diagnostics – Market size and forecast 2020-2025
  • Companion diagnostics – Market size and forecast 2020-2025
  • Market opportunity by Product

Customer landscape

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2020-2025
  • Europe – Market size and forecast 2020-2025
  • Asia – Market size and forecast 2020-2025
  • ROW – Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMerieux SA
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Illumina Inc.
  • Myriad Genetics Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports. 
Technavio’s SUBSCRIPTION platform

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Report: www.technavio.com/report/cancer-diagnostic-devices-market-industry-analysis
Newsroom: newsroom.technavio.com/news/cancer-diagnostic-devicesmarket


Technavio (PRNewsfoto/Technavio)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/global-cancer-diagnostic-devices-market–analyzing-growth-in-health-care-equipment-industry–emerging-trends-company-risk-and-key-executives-technavio-301328793.html

SOURCE Technavio

[ad_2]

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button